December 25, 2014 3:50 PM ET

Capital Markets

Company Overview of ProVen Health VCT plc

Executive Profile

Edmund Olivier de Vezin

AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 0 different industries.

75--

Background

Mr. Edmund Olivier de Vezin has been a Partner of Oxford Bioscience Partners LP (“Oxford Bioscience Partners”) since 1992. Prior to entering the venture capital field in 1984, Mr. de Vezin managed domestic and international operations for Diamond Shamrock, Corning Glass Works and Conoco Chemicals. He served as the Chairman of Biotechnology Venture Investors Group. He serves as a Director of Ceres Inc., Exonhit and Genicon Sosei Inc. He has been a Director of Serono Genetics ...

Corporate Headquarters

39 Earlham Street
London, -- WC2H 9LT

United Kingdom

Phone: 44 20 7845 7820
Fax: 44 20 7845 7821

Board Members Memberships

1994-N/A
Director

Education

MBA
Harvard University
BS
Rice University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ProVen Health VCT plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.